Transformative partnership between the Medicines Patent Pool and ViiV Healthcare enables 24 million people in low- and middle-income countries to acce
10 years on, access-oriented voluntary licensing agreements between ViiV Healthcare and the Medicines Patent Pool, and directly with Aurobindo Pharma, have enabled large scale access to dolutegravir, a WHO-recommended antiretroviral for treatment of people living with HIV. This partnership has also evolved to includ...
Source: pharmiweb.com